Semaglutide (Ozempic, Wagovy, Monjourno and Zepbound) Weight Loss Program

In studies, patients lost, on average, 15% of their body weight with Semaglutide (Ozempic & Wegovy)

This is the newest and most requested group of drugs that has revolutionized weight loss treatment. These medications affect the part of the brain that suppress your appetite and signal you to feel full.

You still need to diet and exercise, but can achieve significant loss of weight. Actually, research has proven that a patient can lose up to 15% of their body weight. It has also been found to diminish the risk of diabetes, heart disease and cancer.
Semaglutide (Ozempic, Wagovy, Monjourno and Zepbound) Weight Loss Program
shutterstock_1657760437

First Doctors Weight Loss Looks Beyond the Scales

Semaglutide (Ozempic & Wegovy) can offer several sustainable weight management benefits when used as part of a comprehensive approach to weight loss and maintenance for those who struggle with weight management. Semaglutide (Ozempic & Wegovy) in conjunction with other First Doctors Maintenance Program measures can offer weight loss that allows you to stay at the healthy weight you desire. The weight loss achieved with Semaglutide (Ozempic & Wegovy) is less likely to be regained compared to some other weight loss methods. This can be particularly important for individuals who have struggled with dieting in the past.

Join First Doctors Weight Loss

Start Losing Weight NOW!

First Doctors Weight Loss does not guarantee any specific weight loss results. Results are personal and vary according to the individual.

Start Losing Weight NOW!

  • Douglasville Office
  • 770.489.8811
  • Hiram Office
  • 678.567.5917
  • Rome Office
  • 706.290.0077
Results are personal and vary according to the individual. First Doctors Weight Loss does not guarantee any specific weight loss results.
  • Douglasville Office
  • 770.489.8811
  • Hiram Office
  • 678.567.5917
  • Rome Office
  • 706.290.0077